Integrating Computational and Experimental Approaches for the Discovery of Multifunctional Peptides from the Marine Gastropod Pisania pusio with Antimicrobial and Anticancer Properties
Authors:
- Ernesto M. Martell-HuguetEMErnesto M. Martell-Huguet
- Thalia Moran-AvilaTMThalia Moran-Avila
- José E. VilluendasJVJosé E. Villuendas
- Armando RodriguezARArmando Rodriguez
- Ann-Kathrin KissmannAKAnn-Kathrin Kissmann
- Ludger StändkerLudger Ständker
- Sebastian WieseSWSebastian Wiese
- Anselmo J. Otero-GonzalezAOAnselmo J. Otero-Gonzalez
- Frank RosenauFRFrank Rosenau
Open Access
- 8 January 2026
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 24 (1) , 32
Abstract
Marine invertebrates are a prime source of biologically active peptides due to their role in humoral immunity. These peptides typically exhibit broad-spectrum functions, including antibacterial, antifungal, anticancer, and immunomodulatory activities. In this report, we describe the identification and biological characterization of five novel bioactive peptides from the marine mollusk Pisania pusio. An extract of P. pusio was analyzed using nanoLC-ESI-MS-MS, and five peptides (PP1–5) were selected via bioinformatic screening as potential antimicrobial and anticancer peptides and subsequently validated experimentally. Among these, PP1, PP2, and PP4 were identified as cryptides derived from the proteolytic cleavage of actin, while PP3 and PP5 are novel peptides with no known protein precursors. All peptides exhibited moderate activity against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae with minimum inhibitory concentrations (MICs) predominantly at 100 µM. In contrast, only PP1 and PP5 were active against cancer cells, with PP1 being the most effective against A375 melanoma cells (IC50 = 17.08 µM). This experimental validation confirmed the utility of the integrated in silico/peptidomic pipeline for lead identification. None of these peptides showed significant hemolytic activity or toxicity on fetal lung fibroblasts over 800 μM, demonstrating promising in vitro selectivity. These results highlight the multifunctional nature of P. pusio-derived peptides and their potential as lead compounds for further optimization and development into therapeutic agents against microbial infections and cancer, subject to more comprehensive safety evaluations in relevant modelsKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (DLR CUB 17WTZ-014/01DN18009)
- German Research Society (DFG) project
This publication has 62 references indexed in Scilit:
- Cationic antimicrobial peptide CC34 potential anticancer and apoptotic induction on cancer cellsAmino Acids, 2025
- Intracellular redistribution of cell-penetrating peptide p28: A mechanism for enhanced anti-cancer activityJournal of Controlled Release, 2025
- ALA‐A2 Is a Novel Anticancer Peptide Inspired by Alpha‐Lactalbumin: A Discovery from a Computational Peptide Library, In Silico Anticancer Peptide Screening and In Vitro Experimental ValidationGlobal Challenges, 2023
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Isolation and functional characterization of an antifungal hydrophilic peptide, Skh-AMP1, derived from Satureja khuzistanica leavesPhytochemistry, 2019
- Computational tools for exploring sequence databases as a resource for antimicrobial peptidesBiotechnology Advances, 2017
- The Neogastropoda: Evolutionary Innovations of Predatory Marine Snails with Remarkable Pharmacological Potential2010
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Cryptides: Functional cryptic peptides hidden in protein structuresPeptide Science, 2007
- Original involvement of antimicrobial peptides in mussel innate immunityFEBS Letters, 2000